NPM1 mutations have been reported to be the most frequent mutations in acute myeloid leukemia (AML). They are associated with a wide spectrum of morphologic subtypes of AML, normal karyotype and FLT3 mutations. The high frequency of NPM1 mutations might provide a suitable marker for monitoring residual disease of AML.
Palmisano M, Grafone T, Ottaviani E, Testoni N, Baccarani M, Martinelli G. (2007). NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia. HAEMATOLOGICA, 92(9):, 1268-1269 [10.3324/haematol.11202].
NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia.
GRAFONE, TIZIANA;OTTAVIANI, EMANUELA;TESTONI, NICOLETTA;BACCARANI, MICHELE;MARTINELLI, GIOVANNI
2007
Abstract
NPM1 mutations have been reported to be the most frequent mutations in acute myeloid leukemia (AML). They are associated with a wide spectrum of morphologic subtypes of AML, normal karyotype and FLT3 mutations. The high frequency of NPM1 mutations might provide a suitable marker for monitoring residual disease of AML.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
